Science Explorer Back to mapMap
Discussion

Clostridium difficile and Clostridium perfringens research

Clostridium difficile and Clostridium perfringens research is a research topic within Infectious Diseases. Science Explorer counts 30k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, treatment, and prevention of Clostridium difficile infection, with a particular emphasis on fecal microbiota transplantation, antibiotic-associated diarrhea, healthcare-associated infections, toxin production, and clinical practice guidelines. It also explores the role of microbiome diversity, vancomycin and metronidazole treatment, risk factors for infection, and bacterial toxins associated with the disease.

  • Fecal Microbiota Transplantation
  • Antibiotic-Associated Diarrhea
  • Healthcare-Associated Infections
  • Toxin Production
  • Epidemiology
  • Clinical Practice Guidelines
  • Microbiome Diversity
  • Vancomycin and Metronidazole Treatment
  • Risk Factors
  • Bacterial Toxins
Research works
30k
fractional, since 1950
In the world top 10%
3k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+11%
the tick is no change
Largest producer
United States
34% of the 10 largest, 2022-now
Clostridium difficile and Clostridium perfringens research
Drawing this view